Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | PDCD1 | Q15116 | 3/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 3/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.34 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.34 |
| ▸ | TOP2A | P11388 | 1/20 | 0.34 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL37187 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL4546275 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL5575995 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL16018595 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL15280759 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL12168228 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL5695275 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL20671060 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL22227398 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM | |
| SCHEMBL4943654 | 1.00 | KMT2A (1.00) | KMT2AMEN1L3MBTL1ALDH1A1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10626249-B2 | Polyolefin compositions | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2020-04-21 | — | — | US | claimed |
| EP-3347413-B1 | POLYOLEFIN COMPOSITIONS | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2019-08-07 | — | — | EP | claimed |
| US-20190023870-A1 | POLYOLEFIN COMPOSITIONS | SABIC GLOBAL TECHNOLOGIOES B.V. (NL) | 2019-01-24 | — | — | US | claimed |
| EP-3347413-A1 | POLYOLEFIN COMPOSITIONS | SABIC Global Technologies B.V. (NL) | 2018-07-18 | — | — | EP | claimed |
| CN-108026340-A | Polyolefin compositions | SABIC环球技术有限责任公司 | 2018-05-11 | — | — | CN | claimed |
| WO-2017042092-A1 | POLYOLEFIN COMPOSITIONS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-03-16 | — | — | WO | claimed |
| EP-1150689-A1 | CHEMICAL COMPOUNDS | NORSK HYDRO ASA (NO) | 2001-11-07 | — | — | EP | claimed |
| WO-2000048609-A1 | CHEMICAL COMPOUNDS | NORSK HYDRO ASA (NO) | 2000-08-24 | — | — | WO | claimed |
| JP-11323309-A | — | — | None | — | — | JP | disclosed |
| US-10626249-B2 | Polyolefin compositions | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2020-04-21 | — | — | US | disclosed |
| EP-3347413-B1 | POLYOLEFIN COMPOSITIONS | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2019-08-07 | — | — | EP | disclosed |
| US-20190023870-A1 | POLYOLEFIN COMPOSITIONS | SABIC GLOBAL TECHNOLOGIOES B.V. (NL) | 2019-01-24 | — | — | US | disclosed |
| CN-108026340-A | Polyolefin compositions | SABIC环球技术有限责任公司 | 2018-05-11 | — | — | CN | disclosed |
| US-9919055-B2 | Sugar-linker-drug conjugates | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2018-03-20 | — | — | US | disclosed |
| US-20120148502-A1 | Carbohydrate-Mediated Tumor Targeting | Arizona Board of Regents, a body corporate of the State of Ariz. acting for and on behalf of Ariz. (US) | 2012-06-14 | — | — | US | disclosed |
| WO-2011019419-A1 | CARBOHYDRATE-MEDIATED TUMOR TARGETING | ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2011-02-17 | — | — | WO | disclosed |
| US-20050077648-A1 | Solution casting method and polymer film | FUJIFILM CORPORATION (JP) | 2005-04-14 | — | — | US | disclosed |
| EP-1150689-A1 | CHEMICAL COMPOUNDS | NORSK HYDRO ASA (NO) | 2001-11-07 | — | — | EP | disclosed |
| WO-2000048609-A1 | CHEMICAL COMPOUNDS | NORSK HYDRO ASA (NO) | 2000-08-24 | — | — | WO | disclosed |
| JP-H11323309-A | GELLING AGENT COMPRISING SUGAR BENZYLIDENE DERIVATIVE | JAPAN SCIENCE & TECHNOLOGY CORP | 1999-11-26 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120148502-A1 | Carbohydrate-Mediated Tumor Targeting | CA14, CA13, CA12 | KMT2A 4059/4885MEN1 550/4885L3MBTL1 4040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.